4//SEC Filing
Leen Ann M. 4
Accession 0001209191-21-017527
CIK 0001754068other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:34 PM ET
Size
8.4 KB
Accession
0001209191-21-017527
Insider Transaction Report
Form 4
Allovir, Inc.ALVR
Leen Ann M.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2021-03-01$38.46/sh−6,359$244,572→ 2,465,326 total(indirect: See Footnote) - Sale
Common Stock
2021-03-01$39.18/sh−3,159$123,758→ 2,462,167 total(indirect: See Footnote)
Holdings
- 28,000
Common Stock
Footnotes (4)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.89 to $38.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.90 to $39.615. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
Allovir, Inc.
CIK 0001754068
Entity typeother
Related Parties
1- filerCIK 0001763026
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:34 PM ET
- Size
- 8.4 KB